CogRx

0 followers

‌

Cognition Therapeutics, Inc. is a clinical-stage neuroscience company developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders.

Industries

Education, Biotechnology

Headquarters

Harrison, United States

Employees

11-50

Links

Org chart

Lisa Ricciardi

CEO

Lisa Ricciardi

Collapse

Gilbert M. Rishton

Co-Founder and Chief Chemist

John Doyle

Chief Financial Officer

Anthony O. Caggiano

Chief Medical Officer And Head Of R&d

Anthony Caggiano

Chief Medical Officer and Head of R&D

Mary Hamby

VP, Research

Theresa Devins

Vice President Clinical Operations

Kelsie Mozzoni LaBarbera

Senior Manager, CMC And Program Management

Teams

+13

Scientific Advisors

16 members

Research and Development Team

7 members

Clinical Operations

4 members

Finance Team

4 members

Leadership Team

3 members

Similar companies

Werewolf Therapeutics

1 follower

eGenesis

1 follower

School District of Philadelphia

4 followers

Bezos Academy

3 followers

Tessera Therapeutics

2 followers

Septerna

2 followers

Vera Therapeutics

2 followers

89bio

2 followers

Neogene Therapeutics

2 followers

Protein Metrics

2 followers

Thurgood Marshall College Fund

1 follower

Explore companies